Lewis T Williams Insider Trading $NLTX Neoleukin Therapeutics, Inc.

FREE EMAIL WATCHDOG

Get free email notifications about insider trading for Lewis T Williams.

Your email is safe with us.
The service is free and you can unsubscribe at any time.

General | Insider Transactions | Monthly Overview

Get the latest insider transactions of Lewis T Williams. Lewis T Williams is Director in BECKMAN COULTER INC ($BEC) and Director in FIVE PRIME THERAPEUTICS INC ($FPRX) and Executive Chairman in FIVE PRIME THERAPEUTICS INC ($FPRX) and President and CEO in FIVE PRIME THERAPEUTICS INC ($FPRX) and President, CEO and Chairman in FIVE PRIME THERAPEUTICS INC ($FPRX) and Director in Protagonist Therapeutics, Inc ($PTGX) and Director in Neoleukin Therapeutics, Inc. ($AQXP).

Lewis T Williams in Neoleukin Therapeutics, Inc.

Trading Symbol: NLTX
Industry: PHARMACEUTICAL PREPARATIONS [2834]
Position of Lewis T Williams: Director
Holdings: 0 shares
Current Value: $0
Latest Transaction: May 13 2021
$NLTX Market Capitalization: $451.60M
$NLTX Previous Close: $18.81

Last 4 weeks trend: HOLD
Last 3 months trend: HOLD

Latest Insider Trading Transactions of Lewis T Williams in Neoleukin Therapeutics, Inc.

	1 Week	2 Weeks	1 Month	3 Months	6 Months	1 Year	2 Years
No. of Purchases	0	0	0	0	0	0	0
Value of Purchases ($)	0	0	0	0	0	0	0
No. of Sales	0	0	0	0	0	0	0
Value of Sales ($)	0	0	0	0	0	0	0

Sentiment: All, BEC, FPRX, NLTX, PTGX

Page: 1

Date	Ticker	Company	Owner	Relationship	Transaction	Code	Cost ($)	Shares	Transaction Value ($)	Total Shares
May 13 2021	NLTX	Neoleukin Therapeu ...	Williams Lewis T	Director	Option Exercise	A	11.40	25,000	285,000	25,000
May 07 2020	NLTX	Neoleukin Therapeu ...	Williams Lewis T	Director	Option Exercise	A	12.84	25,000	321,000	25,000
Oct 15 2019	AQXP	Neoleukin Therapeu ...	Williams Lewis T	Director	Option Exercise	A	2.82	22,000	62,040	22,000
Oct 15 2019	AQXP	Neoleukin Therapeu ...	Williams Lewis T	Director	Option Exercise	A	2.82	22,000	62,040	22,000

Page: 1